Impact of prior treatment with immune checkpoint inhibitors on dacarbazine efficacy in metastatic melanoma

被引：0
|
作者：
Sarah Bouchereau
Louise Chaplain
Magali Fort
Alain Beauchet
Thomas Sidibé
Marie Chapalain
Leire Gonzalez-Lara
Christine Longvert
Astrid Blom
Philippe Saiag
Elisa Funck-Brentano
机构：
[1] Ambroise Paré Hospital,Department of General and Oncologic Dermatology
[2] AP-HP,Department of Public Health
[3] Research unit EA4340 ‘Biomarkers and clinical trials in cancerology and onco-hematology’,Department of Pharmacy
[4] Versailles-Saint-Quentin-en-Yvelines University,undefined
[5] Paris-Saclay University,undefined
[6] GHU Paris-Saclay,undefined
[7] AP-HP,undefined
[8] Ambroise Paré Hospital,undefined
[9] AP-HP,undefined
来源：
British Journal of Cancer | 2021年 / 125卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：948 / 954
页数：6
相关论文
共 50 条
  • [21] Immune checkpoint inhibitors: a milestone in the treatment of melanoma
    Wilden, Sophia M.
    Lang, Berenice M.
    Mohr, Peter
    Grabbe, Stephan
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 (07): : 685 - 695
  • [22] Impact of clinicopathological characteristics on survival in patients treated with immune checkpoint inhibitors for metastatic melanoma
    Zhao, Bin
    Zhao, Hong
    Zhao, Jiaxin
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (01) : 169 - 177
  • [23] Efficacy of immune checkpoint inhibitors in different types of melanoma
    Rossi, Ernesto
    Schinzari, Giovanni
    Maiorano, Brigida Anna
    Indellicati, Giulia
    Di Stefani, Alessandro
    Pagliara, Monica Maria
    Fragomeni, Simona Maria
    De Luca, Erika Valentina
    Sammarco, Maria Grazia
    Garganese, Giorgia
    Galli, Jacopo
    Blasi, Maria Antonietta
    Paludetti, Gaetano
    Scambia, Giovanni
    Peris, Ketty
    Tortora, Giampaolo
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (01) : 4 - 13
  • [24] Efficacy of immune checkpoint inhibitors for in-transit melanoma
    Nan Tie, Emilia
    Lai-Kwon, Julia
    Rtshiladze, Michael Alexander
    Na, Lumine
    Bozzi, James
    Read, Tavis
    Atkinson, Victoria
    Au-Yeung, George
    Long, Georgina
    McArthur, Grant A.
    Sandhu, Shahneen
    Saw, Robyn
    Walpole, Euan
    Menzies, Alexander
    Smithers, Mark
    Gyorki, David E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [25] Cardiovascular Immunotoxicity Associated with Immune Checkpoint Inhibitors in Metastatic Melanoma
    L'Orphelin, Jean-Matthieu
    Dollalille, Charles
    Akroun, Julia
    Alexandre, Joachim
    Dompmartin, Anne
    CANCERS, 2023, 15 (07)
  • [26] Surgery in patients with metastatic melanoma treated with immune checkpoint inhibitors
    Janssen, Josephine C.
    Huibers, Anne E.
    Grunhagen, Dirk J.
    Bagge, Roger Olofsson
    SCANDINAVIAN JOURNAL OF SURGERY, 2025,
  • [27] Immune checkpoint inhibitors in melanoma in the metastatic, neoadjuvant, and adjuvant setting
    Herrscher, Hugo
    Robert, Caroline
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (02) : 106 - 113
  • [28] Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
    Gide, Tuba N.
    Wilmott, James S.
    Scolyer, Richard A.
    Long, Georgina V.
    CLINICAL CANCER RESEARCH, 2018, 24 (06) : 1260 - 1270
  • [29] Cytokine Release Syndrome During Sequential Treatment With Immune Checkpoint Inhibitors and Kinase Inhibitors for Metastatic Melanoma
    Dimitriou, Florentia
    Matter, Alexandra V.
    Mangana, Joanna
    Urosevic-Maiwald, Mirjana
    Micaletto, Sara
    Braun, Ralph P.
    French, Lars E.
    Dummer, Reinhard
    JOURNAL OF IMMUNOTHERAPY, 2019, 42 (01) : 29 - 32
  • [30] Eosinophilic Fasciitis by Treatment with Checkpoint Inhibitors in metastatic Melanoma
    Toussaint, F.
    Erdmann, M.
    Moreira, A.
    Kirchberger, M. C.
    Schuler, G.
    Heinzerling, L.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 76 - 76
12345